SAGE Therapeutics Inc. (SAGE) Surged After FDA Discussion

SAGE Therapeutics Inc. (SAGE) announced an expedited development plan for SAGE-217 Tuesday morning, after a Breakthrough Therapy meeting with the FDA.

from RTT - Before the Bell https://ift.tt/2JIEWtB
via IFTTT